TD-198946 is primarily utilized in the field of medicinal chemistry for its potential therapeutic properties. It is being investigated for its role as a selective inhibitor targeting specific enzymes or receptors involved in disease pathways. Researchers are exploring its application in treating conditions such as inflammatory disorders, cancers, and metabolic diseases due to its ability to modulate key biological processes. Additionally, TD-198946 is studied for its pharmacokinetic properties, including bioavailability and metabolic stability, to assess its suitability as a drug candidate. Its unique chemical structure allows it to interact with biological targets with high specificity, making it a promising compound for further drug development and clinical trials.